| Canlas Medical Corporation | |
|
23517 Main St Suite 108 Carson CA 90745-5251 | |
| (310) 518-6246 | |
| Not Available |
| Full Name | Canlas Medical Corporation |
|---|---|
| Speciality | Internal Medicine |
| Location | 23517 Main St, Carson, California |
| Authorized Official Name and Position | Maria Cecilia S Canlas (PRESIDENT) |
| Authorized Official Contact | 3105186246 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Canlas Medical Corporation 23517 Main St Suite 108 Carson CA 90745-5251 Ph: (310) 518-6246 | Canlas Medical Corporation 23517 Main St Suite 108 Carson CA 90745-5251 Ph: (310) 518-6246 |
| NPI Number | 1114147089 |
|---|---|
| Provider Enumeration Date | 04/26/2007 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114147089 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
News Archive
Medicis today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,790,705 related to the use of SOLODYN® (minocycline HCI, USP) Extended Release Tablets. The new patent, entitled "Minocycline Oral Dosage Forms for the Treatment of Acne," relates to the use of dosage forms of SOLODYN which provide approximately 1 mg/kg dosing based on the body weight of the person, and expires in 2027.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor biased ligands, announced today initiation of dosing in BLAST-AHF, the Company's randomized, multi-center Phase 2b trial of TRV027 in patients with acute heart failure.
Ipsen and Syntaxin, a biotechnology company specialising in innovative biopharmaceutical therapies targeting cell secretion pathways, announced today a global strategic collaboration to explore the discovery and development of new compounds in the field of botulinum toxins.
Use of hormone replacement therapy (HRT) increases the risk of gallbladder disease but the effects are less with HRT given in skin patches or gels compared with HRT given orally, according to a study published on BMJ.com today.
› Verified 4 days ago
Sage Wellness Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 460 E Carson Plaza Dr, #114, Carson, CA 90746 Phone: 310-746-5500 | |
Bhs Carson Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1000 E Dominguez St, Carson, CA 90746 Phone: 310-830-4561 Fax: 310-830-0210 | |
Argent Medical Group, Incorporated Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 23251 Main St, Carson, CA 90745 Phone: 310-830-4561 Fax: 310-830-0210 | |
Summit Healthcare Ipa Corp. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 23049 Archibald Ave, Carson, CA 90745 Phone: 310-850-5630 Fax: 888-444-9401 | |
Jed Padre Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 282 E Sepulveda Blvd, Carson, CA 90745 Phone: 310-518-6861 Fax: 310-835-1366 | |
Shrikant Tamhane Do Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 23517 Main St Ste 103, Carson, CA 90745 Phone: 310-834-5388 Fax: 310-834-5619 |